FMC Corp

FMC: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|yb$l&!>LOCK|$<LOCK|@Yr

FMC Earnings: Turnaround Remains Underway as Diamide Patent Expirations Weigh on Profits

FMC reported a 40% year-over-year adjusted EBITDA decline drive primarily by patent expirations in the company's diamide insecticide portfolio. FMC shares were up 8% at the time of writing as the market reacted to new products driving volume growth.

Sponsor Center